Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Bionime Corporation

Clinicaltrial registered22 Oct 2026

Bionime Corporation

22 Oct 2026: Trial registered · RIGHTEST iFree 2 CGM System for Glycemic Control in Adults With Diabetes Mellitus. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
22 Oct 2026
Title
RIGHTEST iFree 2 CGM System for Glycemic Control in Adults With Diabetes Mellitus
Conditions
Diabetes (DM)
Phase
Not applicable
Study Type
Interventional
Status
Recruiting
Countries
Taiwan
Country
Taiwan
Reference
NCT07889375
Location
Taiwan
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Bionime Corporation

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for Bionime Corporation in our registers.

More from Taiwan

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.